Antibodies for Cancer Therapy

This conference focuses on the current status of therapeutic antibodies and the outlook for the future. This year's agenda will highlight diverse topics such as identifying and validating novel targets, optimizing drug-like properties, increasing tumor penetration, employing novel constructs, and regulating novel therapeutic antibodies. Emphasis will be placed on learning from molecules in clinical development. Plan to attend to review the vibrant community of therapeutic antibodies and discover the latest trends for future best-in-class drugs.